United States Diagnostics Market Size, Share, Trend and Forecast 2026 | TechSci Research

1
PUBLISHED MAY 2021
2016 2026
United States Diagnostics Market
FORECAST AND OPPORTUNITIES
www.techsciresearch.com
MARKET INTELLIGENCE . CONSULTING
2

• Table of Contents

S. No. Contents Contents Contents
1. Product Overview Product Overview Product Overview
2. Research Methodology Research Methodology Research Methodology
3. Impact of COVID-19 on United States Diagnostics Market Impact of COVID-19 on United States Diagnostics Market Impact of COVID-19 on United States Diagnostics Market
4. Executive Summary Executive Summary Executive Summary
5. Voice of Customer Voice of Customer Voice of Customer
5.1. Brand Awareness Brand Awareness
5.2. Reasons for Getting Diagnostic Test Done Reasons for Getting Diagnostic Test Done
5.3. Preferred Choice of Setup for Diagnostic Test Preferred Choice of Setup for Diagnostic Test
6. United States Diagnostics Market Outlook United States Diagnostics Market Outlook United States Diagnostics Market Outlook
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Product Type (Reagents, Instruments, Software Services)
6.2.2. By Type of Test (Infectious Disease Testing, Lipid Panel Test, Metabolic Panel Test, Others)
6.2.3. By Technique (Immunodiagnostics, Clinical Techniques, Molecular Diagnostics, Tissue Diagnostics, Others)
6.2.4. By Usability (Reusable v/s Disposable)
6.2.5. By Application (Infectious Diseases Human Papillomavirus, Hepatitis, Tuberculosis, Hospital-Acquired Infections, COVID-19, Cancer Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Liver Cancer, Others, Sexually Transmitted Diseases Chlamydia Trachomatis Infection, Gonorrhoea, Syphilis, Others, Others)
6.2.6. By End User (Hospitals, Public Labs, Diagnostic Centers, Point-of-care Testing Centers, Private or Commercial Laboratories, Others)
3

• Table of Contents

S. No. Contents Contents Contents
6.2.7 By Region (South West Mid-West and North-East)
6.2.8. By Company (2020)
6.2.9. Company-Wise List of Major Diagnostics Kits Approved
6.3. Market Map (By Product Type, By Type of Test, By Technique, By Usability) Market Map (By Product Type, By Type of Test, By Technique, By Usability)
7. United States Infectious Disease Testing Market Outlook United States Infectious Disease Testing Market Outlook United States Infectious Disease Testing Market Outlook
7.1. Market Size Forecast Market Size Forecast
7.1.1. By Value
7.2. Market Share Forecast Market Share Forecast
7.2.1. By Product Type
7.2.2. By Technique
7.2.3. By Usability
7.2.4. By Application
7.2.5. By End User
7.2.6. By Region
8. United States Lipid Panel Test Market Outlook United States Lipid Panel Test Market Outlook United States Lipid Panel Test Market Outlook
8.1. Market Size Forecast Market Size Forecast
8.1.1. By Value
8.2. Market Share Forecast Market Share Forecast
8.2.1. By Product Type
8.2.2. By Technique
8.2.3. By Usability
8.2.4. By Application
8.2.5. By End User
4

• Table of Contents

S. No. Contents Contents Contents Contents
8.2.6. By Region By Region
9. United States Metabolic Panel Test Market Outlook United States Metabolic Panel Test Market Outlook United States Metabolic Panel Test Market Outlook United States Metabolic Panel Test Market Outlook
9.1. Market Size Forecast Market Size Forecast Market Size Forecast
9.1.1. By Value By Value
9.2. Market Share Forecast Market Share Forecast Market Share Forecast
9.2.1. By Product Type By Product Type
9.2.2. By Technique By Technique
9.2.3. By Usability By Usability
9.2.4. By Application By Application
9.2.5. By End User By End User
9.2.6. By Region By Region
10. Market Dynamics Market Dynamics Market Dynamics Market Dynamics
10.1. Drivers Drivers Drivers
10.2. Challenges Challenges Challenges
11. Market Trends and Developments Market Trends and Developments Market Trends and Developments Market Trends and Developments
12. Policy and Regulatory Landscape Policy and Regulatory Landscape Policy and Regulatory Landscape Policy and Regulatory Landscape
13. United States Economic Profile United States Economic Profile United States Economic Profile United States Economic Profile
14. Competitive Landscape Competitive Landscape Competitive Landscape Competitive Landscape
14.1. Competition Outlook Competition Outlook Competition Outlook
14.2. Company Profiles Company Profiles Company Profiles
14.2.1. 14.2.1. Abbott Laboratories, Inc.
14.2.2. 14.2.2. Danaher Corporation
14.2.3. 14.2.3. Thermo Fischer Scientific, Inc.
5

• Table of Contents

S. No. Contents Contents Contents
14.2.4. Johnson Johnson
14.2.5. Ortho-Clinical Diagnostics, Inc.
14.2.6. Becton, Dickinson and Company
14.2.7. Bio-Rad Laboratories, Inc.
14.2.8. Roche Diagnostics Corporation
14.2.9. Siemens Medical Solutions USA, Inc.
14.2.10. Biomerieux Inc.
15. Strategic Recommendations Strategic Recommendations Strategic Recommendations
16. About Us Disclaimer About Us Disclaimer About Us Disclaimer
6
PRODUCT OVERVIEW
7

• Scope of Report
• Product of Interest (POI) Diagnostics

Diagnostics include various practices or
techniques used for different diseases or
conditions which explain a patients symptoms and
signs. There are many tests or procedures used to
diagnose the prevalence and severity of various
diseases or ailments. All these tests or
procedures performed for the identification and
treatment of different diseases or conditions are
part of diagnostics. Diagnostic tests and
procedures help in early diagnosis of diseases so
that the treatment can be provided on time.
Additionally, diagnostic procedures are helpful
once a patient suffers from a certain disease to
identify the stage of the disease whether it is
acute or chronic. This in turn helps the
physicians/doctors to provide appropriate
treatment to their patients and also patients
become aware about the severity of their disease.
Market Segmentation

BY REGION
BY APPLICATION
BY PRODUCT TYPE
BY TECHNIQUE

• South
• Mid-West
• West
• North-East

• Reagents
• Instruments
• Software Services

• Immunodiagnostics
• Clinical Techniques
• Molecular Diagnostics
• Tissue Diagnostics
• Others

• Infectious Diseases
• Cancer
• Sexually Transmitted Diseases
• Others

BY TYPE OF TEST

• Infectious Disease Testing
• Lipid Panel Test
• Metabolic Panel Test
• Others

BY END USER
BY USABILITY

• Hospitals
• Public Labs
• Diagnostic Centers
• Point-of-Care Testing Centers
• Private or Commercial Laboratories
• Others

• Reusable
• Disposable

8
RESEARCH METHODOLOGY
9

• Research Methodology

• Identifying Key Opinion Leaders
• Questionnaire Design
• In-depth Interviews

• Recent Developments
• Market Changing Aspects/Dynamics
• Government Policies
• Final Conclusion

• Market Participants
• Key Strengths

10
Research Methodology
For executing the study, TechSci Research used
bottom-up model, which was later on cross
validated by using top-down approach. TechSci
Research followed a mix of exhaustive secondary
research and primary research for this
study. Phase 1 Initially, TechSci Research
would try to source the list of diagnostics
service providers worldwide. Then, primary
research surveys will be conducted with the
identified companies, and they will also be asked
for their other competitors in the market. By
this way if we may have missed any target company
due to limitations of secondary research then we
will be able to identify that company and then
survey them as well. Below mentioned is the
tentative number of surveys that were conducted
during the study
Product/ Stakeholders Service Providers Distributors/Dealers Industry Experts Total
Diagnostics 3040 100-150 20-25 200
11

• Research Methodology

Phase 2 For the study, TechSci Research has
gathered information through primary research
surveys with leading diagnostic companies of
various regions across the United States, and
subsequently, verified information from prominent
companies engaged in the diagnostics market,
worldwide. Exhaustive search of credible paid
databases such as Factiva, Hoovers, etc.,
including our internal database. Our team of
analysts has then prudently evaluated all the
collected information and presented the same in a
chronological order to depict a meaningful and
clear picture of United States diagnostics
market. While compiling the data, we have also
cross checked all the collected information from
multiple sources and data warehouses, to present
the most accurate and precise information of the
concerned industry.
Some Sources of Secondary Research
Primary Research Prominent Companies
Associations Interviewed
S. No. Company Name
1 Abbott Laboratories, Inc.
2 Danaher Corporation
3 Thermo Fisher Scientific, Inc.
4 Johnson Johnson
5 Ortho-Clinical Diagnostics, Inc.
6 Becton, Dickinson, and Company
7 Bio-Rad Laboratories, Inc.
8 Roche Diagnostics Corporation
9 Siemens Medical Solutions USA, Inc.
10 Biomerieux Inc.
S. No. Secondary Source
1 World Bank
2 TechSci Research Proprietary Database Knowledge Repository
3 Company Annual Reports
4 Industry Magazines
5 Industry Reports
6 Credible Paid Databases
7 WHO Reports Data
8 American Clinical Laboratory Association
9 American Hospital Association
10 Centers for Disease Control and Prevention
11 Food and Drug Administration
12 American Cancer Society
12

• Research Methodology

• Phase 3 TechSci Research performed periodical
  checks on data being collected through surveys
  with logic checks and analyze survey results in
  MS Excel/SPSS and data generated through its
  proprietary database.
• TechSci Research also used data triangulation
  technique to fill the gaps and to present the
  more meaningful picture of the market. In order
  to forecast the United States diagnostics market,
  TechSci Research used various forecast techniques
  such as
• Moving Average
• Time Series Analysis
• Regression analysis
• Econometric and Judgmental Analysis
• TechSci Research also used its own forecasting
  tool, which is based on the growth of various
  allied industries. TechSci also used impact
  analysis during short, medium and long term to
  estimate the demand and to reach to an accurate
  market numbers.
• Phase 4 TechSci Research prepared the final
  comprehensive project report in detailed
  PowerPoint Presentation format along with the
  supporting documents.

13

• Industry Brief

According to TechSci Research report, United
States Diagnostics Market By Product Type
(Reagents, Instruments, Software Services), By
Type of Test (Infectious Disease Testing, Lipid
Panel, Metabolic Panel, Others), By Technique
(Immunodiagnostics, Clinical Techniques,
Molecular Diagnostics, Tissue Diagnostics,
Others), By Usability (Reusable v/s Disposable),
By Application (Infectious Diseases (Human
Papillomavirus, Hepatitis, Tuberculosis,
Hospital-Acquired Infections, COVID-19), Cancer
(Breast Cancer, Lung Cancer, Colorectal Cancer,
Melanoma, Liver Cancer, Others), Sexually
Transmitted Diseases (Chlamydia Trachomatis
Infection, Gonorrhoea, Syphilis, Others),
Others), By End User (Hospitals, Public labs,
Diagnostic Centers, Point-of-Care Testing
Centers, Private or Commercial Laboratories,
Others), By Region, Forecast Opportunities,
2026, the United States diagnostics market stood
at USD30.08billion in 2020 and is expected to
grow at a steady rate of 5.17 during the
forecast period on account of the changing
lifestyle and dietary habits of the people. This
has led to an increase in the prevalence of
diseases such as cancer, diabetes, asthma,
cardiovascular diseases, renal disorders,
hypertension, among others. Statistics show that
every year more than 1.5 million people die
because of these diseases in the country. This
has increased the demand for diagnostics in the
country so that such diseases could be detected
early, and the patients can get appropriate
treatment. Additionally, growing number of
accredited laboratories, point-of-care testing
centers, hospitals, among others is expected to
further fuel the market growth. Furthermore,
increasing penetration of health insurance
providers is expected to create lucrative
opportunities for the market growth. However,
dearth of skilled professionals in the
laboratories might hamper the market growth
through 2026. Additionally, need for high
complexity testing centers might further restrict
the market growth over the next few years. Also,
high cost of tests and budget constraints might
further hinder the market growth during the
forecast period. The United States diagnostics
market is segmented based on product type, type
of test, technique, usability, application, end
user, company and region. Based on type of test,
the market can be segmented into infectious
disease testing, lipid panel test, metabolic
panel test and others. The infectious disease
testing segment is expected to dominate the
market in 2020 with a share of around 43.35 and
will continue maintaining its dominance over the
forecast period. A drastic increase in market
share was observed in 2020 owing to the sudden
outbreak and spread of COVID-19 in the country
which significantly increased the testing.
Additionally, United States witnesses prevalence
of several other infectious diseases such as
human papillomavirus, hepatitis, among others.
Lipid panel tests are expected to witness
significant growth during the forecast period
owing to the increasing prevalence of
cardiovascular diseases in the country. Based on
technique, the market can be categorized into
immunodiagnostics, clinical techniques, molecular
diagnostics, tissue diagnostics and others. The
immunodiagnostics technique held the highest
market share and will continue maintaining its
dominance over the forecast period owing to the
widespread use of immunodiagnostic technique in
infectious disease testing and identification of
microbes, such as fungus, bacteria, and viruses,
by detection of their toxins. Additionally,
increasing prevalence of chronic diseases, such
as HIV, and the introduction of instruments with
higher accuracy are further expected to drive the
market growth. While the tissue diagnostics and
molecular diagnostics segments are expected to
witness growth in the coming years owing to the
increasing prevalence of different types of
cancers across United States. Based on
application, the market can be fragmented into
infectious diseases, cancer, sexually transmitted
diseases and others. The infectious disease
segment dominated the market in 2020 and is
expected to maintain its dominance over the
forecast period owing to the prevalence of
various infectious diseases in the United States.
The spread of COVID-19 significantly increased
the segmental shares in 2020. The cancer segment
is expected to witness significant growth through
2026 owing to the increase in prevalence of
various kinds of cancers in the country. Also,
sexually transmitted diseases are expected to
grow significantly in the future and witness
growth, especially Chlamydia Trachomatis
infection and Gonorrhoea. Abbott Laboratories,
Inc., Danaher Corporation, Thermo Fisher
Scientific, Inc., Johnson Johnson,
Ortho-Clinical Diagnostics, Inc., Becton,
Dickinson, and Company, Bio-Rad Laboratories,
Inc., Roche Diagnostics Corporation, Siemens
Medical Solutions USA, Inc., Biomerieux Inc. and
others are some of the leading players operating
in United States diagnostics market. The
companies operating in the market are using
organic strategies such as product launches,
mergers and collaborations to boost their share.
Cell-DYN Sapphire, CELL-DYN Ruby and CELL-DYN
Emerald 22 AL are hematology analyzers developed
by Abbott Laboratories, Inc. and the company has
launched coronavirus tests which require m2000
Real Time PCR system. The emergence of COVID-19
led to the development of COVID-19 testing kits
and PCR devices for diagnosis. For instance, the
Bio-Rad Laboratories developed Platelia
SARS-CoV-2 Total Ab Assay, which detects the
total anti-nucleocapsid antibodies against
coronavirus SARS-CoV-2 in 2020. The company also
formulated Coronavirus Ag Rapid Test Cassette
(Swab) and BioPlex 2200 SARA-CoV-2 IgG Panel.
United States diagnostics market is expected to
witness steady growth during the forecast period
on account of the increasing demand for
personalized medicines and companion diagnostics.
Additionally, technological advancements in the
healthcare industry with the advent of AI, cloud
computing, IoT, among others, is further expected
to propel the market growth through 2026.
Additionally, presence of major pharmaceutical
biotechnology giants in the country is further
expected to create lucrative opportunities for
the market growth over the next few years. said
Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management
consulting firm.
14

• Sample Data - Snapshot

United States Diagnostics Market Size, By Value
(USD Billion), 2016-2026F
United States Diagnostics Market Share, By
Product Type, By Value, 2016-2026F
United States Infectious Disease Testing Market
Share, By Technique, By Value, 2016-2026F
15

• Report Ordering

• Report Name United States Diagnostics
  Market
• Forecast and Opportunities
• 2016 2026

License Type Price
Single User License 3500
Multi-User License 4500
Custom Research License 7500
To View Sample OR Purchase Report  
16
About Us Disclaimer
TechSci Research is a global market research and
consulting company with offices in the US, UK and
India. TechSci Research provides market research
reports in number of areas to organizations. The
company uses innovative business models that
focus on improving productivity, while ensuring
creation of high-quality reports. The proprietary
forecasting models use various analyses of both
industry-specific and macroeconomic variables on
a state-by-state basis to produce a unique
bottom-up model of a country, regional and
global industry prospects. Combined with the
detailed analysis of company activity and
industry trends, the result is a uniquely rich
evaluation of the opportunities available in the
market.
Related Reports

• Global Diagnostic Electrocardiograph Market By
  Product Type (Resting ECG Devices, Stress ECG
  Devices, Holter Monitors, Others), By Channel
  (12-channel, 6-channel, 5- channel, 3- channel,
  Single- channel), By End User (Hospitals
  Clinics, Ambulatory Surgical Centers, Cardiac
  Care Centers, Others), By Region, Competition
  Forecast Opportunities, 2026
• Global Diagnostic Imaging Market By Product Type
  ( Architecture (Open/Closed), By Field Strength
  (High and Very-High Field MRI Systems), By
  Systems (Ultrasound Systems, Nuclear Imaging
  Systems, X-Ray Imaging Systems, CT Scanner, MRI
  System, Mammography System, Fluoroscopy), By
  Portability (Stationary, Portability), By
  Application (OB/Gyn, Orthopaedic,
  Musculosekeletal, Neuro Spine, General Imaging,
  Cardio Thoracic, Breast health, Others), By End
  Users (Hospitals, Diagnostic Imaging Centers,
  Others), By Region, Forecast Opportunities,
  2016-2026F

TechSci Research North America 708 Third
Avenue, Manhattan, New York, United States Tel
1- 646- 360- 1656 Email sales_at_techsciresearch.co
m www.techsciresearch.com
TechSci Research Europe 54, Old brook,
Bretton, Peterborough, United Kingdom Email
sales_at_techsciresearch.com www.techsciresearch.com
TechSci Research Asia-Pacific B 44, Sector
57, Noida, National Capital Region, U.P. -
India Tel [phone] Email
sales_at_techsciresearch.com www.techsciresearch.com
Disclaimer
The contents of this report are based on
information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. TechSci Research has taken
due care and caution in compilation of data as
this has been obtained from various sources
including which it considers reliable and first
hand. However, TechSci Research does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
TechSci Research.